Encephalopathy as a form of presentation of COVID-19
Keywords:
COVID-19, coronavirus infection, encephalopathy, acyclovir, ventricular peritoneal shunt.Abstract
Introduction: SARS-CoV-2 virus, responsible for COVID-19, has a high contagion rate and is capable of producing conditions at different levels in the body, and includes the central nervous system, with manifestations such as febrile and afebrile seizures, status epilepticus, encephalopathies and encephalitis.Objective: To describe a patient with encephalopathy, as a form of presentation of COVID-19.
Clinical case: A 25-year-old patient with a history of post-traumatic obstructive hydrocephalus, with ventricular peritoneal shunt, positive for COVID-19, who developed neurological manifestations, in the absence of respiratory manifestations. He was treated according to the protocol for patients with COVID-19, anti-cerebral edema measures and use of the CIGB-258 peptide. The patient had a favorable evolution towards recovery
Conclusions: In patients with encephalopathy of unknown cause, in the context of the COVID-19 pandemic, SARS-CoV-2 infection should be considered. The evolution can be favorable with the use of general measures and anti-cerebral edema.
Downloads
Download data is not yet available.
References
1. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018 [acceso: 15/08/2020]; 12:386. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212673/pdf/fncel-12-00386.pdf
2. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 [acceso: 15/08/2020]; 8(4): 420-22. Disponible en: https://www.mediclinic.co.za/content/dam/mc-sa-corporate/downloads/pathological-findings-of-covid-19-associated-with-ards.pdf
3. Abenza-Abildúa MJ, Ramírez-Prieto MT, Moreno-Zabaleta R, Arenas-Valls N, Salvador-Maya MA, Algarra-Lucas C, et al. Complicaciones neurológicas en pacientes críticos por SARS-CoV-2. Neurologia. 2020 [acceso: 15/08/2020]; 35(9): 621-27. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402100/pdf/main.pdf
4. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China. JAMA Neurol. 2020 [acceso: 21/11/2020]; 77(6): 683-90. Disponible en: https://jamanetwork.com/journals/jamaneurology/article-abstract/2764549
5. Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020 [acceso: 21/11/2020]; 70(9): 311-22. Disponible en: https://www.areasaludbadajoz.com/docencia_investigacion/lecturas_recomendadas/Te_puede_interesar-_COVID-19/revista_espa%C3%B1ola_de_neurologia.pdf
6. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020 [acceso: 21/11/20]; 77(8):1018-27. Disponible en: https://jamanetwork.com/journals/jamaneurology/article-abstract/2766766
2. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 [acceso: 15/08/2020]; 8(4): 420-22. Disponible en: https://www.mediclinic.co.za/content/dam/mc-sa-corporate/downloads/pathological-findings-of-covid-19-associated-with-ards.pdf
3. Abenza-Abildúa MJ, Ramírez-Prieto MT, Moreno-Zabaleta R, Arenas-Valls N, Salvador-Maya MA, Algarra-Lucas C, et al. Complicaciones neurológicas en pacientes críticos por SARS-CoV-2. Neurologia. 2020 [acceso: 15/08/2020]; 35(9): 621-27. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402100/pdf/main.pdf
4. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China. JAMA Neurol. 2020 [acceso: 21/11/2020]; 77(6): 683-90. Disponible en: https://jamanetwork.com/journals/jamaneurology/article-abstract/2764549
5. Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020 [acceso: 21/11/2020]; 70(9): 311-22. Disponible en: https://www.areasaludbadajoz.com/docencia_investigacion/lecturas_recomendadas/Te_puede_interesar-_COVID-19/revista_espa%C3%B1ola_de_neurologia.pdf
6. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020 [acceso: 21/11/20]; 77(8):1018-27. Disponible en: https://jamanetwork.com/journals/jamaneurology/article-abstract/2766766
Published
2021-12-03
How to Cite
1.
Nuñez Martínez JF, Madruga Vásquez C, Hernández Fernandez R, Pérez Ciprián G, Bouza Denis I. Encephalopathy as a form of presentation of COVID-19. Rev Cubana Med Milit [Internet]. 2021 Dec. 3 [cited 2025 Jan. 14];50(4):e02101179. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1179
Issue
Section
Case Presentation
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.
